GlycatedAlbumin(Glycoalbumin) | |
Manufacturer/Trade: | Exocell/Glycaben |
CatalogueNumbers: | Glycaben:1003StripPlate |
Methodology: | SandwichELISA |
Summaryofprocedure: | Glycabenisanenzymelinkedimmunosorbentassayforthequantitativedeterminationofglycoalbumininhumanplasma.Itprovidesinformationconcerningglycemiccontrolanalogoustothatofferedbyglycohemoglobinmeasurements,exceptthattheproteinmeasuredisglycatedalbuminwhichhasashorterhalf-life. Theassaydependsuponamonoclonalantibody,A717,thatspecificallyrecognizestheglycatedmoietiesinglycatedalbumin.Inpractice,standardsorsamplesareaddedtoA717coatedplates(Glycaben).Theglycoalbuminintheseanalytesbindstooriscapturedbytheantibodyonthesolidphase,andunboundmaterialsarewashedaway.Asubsequentincubationwithanenzymeconjugatedantihumanalbuminantibodyleadstodetectionoftheboundmolecules.BoundconjugateisdeterminedcolorimetricallyafterreactionwithaTMBsubstratesolution. Byrelatingsampleresponsewiththatforthestandards,theconcentrationofglycoalbuminmaybedetermined.Aseparateanalysisoftotalalbuminallowstheresultstobeconvertedtopercentoftotalalbuminthatisglycated. |
SpecimenRequired: | 50ulcitrateorEDTAtreatedplasma |
AssayRange: | 0.1-3mg/mlglycatedalbumin |
Sensitivity: | 0.1mg/ml |
Precision: | Intra-andinterassayprecisionofsampleswithintheassayrangehaveaC.V.<10%. |
Specificity: | ThemonoclonalantibodyA717isspecificforglycatedalbumin,anddoesnotcross-reactwithotherproteinsthatoccurinhumanplasmaincludingnon-glycatedalbumin.Theenzymeconjugatedantibodypreparationisspecificforhumanalbumin. |
ExpectedValues: | Plasmafromnormalnon-diabeticindividualhave0.4-2.4%glycatedalbuminwhereasthatfromuncontrolleddiabeticswillbe>2.5%. |
©2012ExocellInc. |